⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Edwards Lifesciences Corp (E1WL34)

B3
Currency in BRL
106.15
0.00(0.00%)
Closed

E1WL34 Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4,3484,386.35,232.55,382.46,004.8
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.79%+0.88%+19.29%+2.86%+11.56%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,114.41,080.61,248.91,078.81,379.8
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa3,233.63,305.73,983.64,303.64,625
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.17%+2.23%+20.51%+8.03%+7.47%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa74.37%75.36%76.13%79.96%77.02%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1,995.11,989.52,397.12,511.72,895.2
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+16.63%-0.28%+20.49%+4.78%+15.27%
aa.aaaa.aaaa.aaaa.aaaa.aa752.7760.7903.1945.21,071.8
aa.aaaa.aaaa.aaaa.aaaa.aa1,242.41,228.81,4941,566.51,823.4
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,238.51,316.21,586.51,791.91,729.8
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+15.45%+6.27%+20.54%+12.95%-3.47%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa28.48%30.01%30.32%33.29%28.81%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa11.57.6-116.349.6
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+447.62%-33.91%-113.16%+1,730%+204.29%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-20.7-15.8-18.4-19.2-17.6
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa32.223.417.435.567.2
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa8.812.215.817.622
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,258.81,3361,601.31,825.81,801.4
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-91.9-419103.523.8-194.5
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,166.5916.71,7021,767.41,598.1
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+53.2%-21.41%+85.67%+3.84%-9.58%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa26.83%20.9%32.53%32.84%26.61%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa119.693.3198.9245.5198.7
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa1,046.9823.41,503.11,521.91,399.4
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa----3
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,046.9823.41,503.11,521.91,402.4
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+44.96%-21.35%+82.55%+1.25%-7.85%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa24.08%18.77%28.73%28.28%23.35%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,046.9823.41,503.11,521.91,402.4
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.681.322.412.462.31
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+45.61%-21.07%+82.34%+1.95%-5.98%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.641.32.382.442.3
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+45.13%-20.73%+83.08%+2.52%-5.74%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa624.8622.6623.3619606.7
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa636.7631.9631.2624.2609.4
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa1,327.81,423.41,721.31,931.51,874.7
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+15.44%+7.2%+20.93%+12.21%-2.94%